Palatin Share Price
NASDAQ: PTN | Micro Cap | HealthcarePalatin Stock Performance
Palatin Share Price Chart
Palatin Quarterly Profit & Loss
All figures in USD
Palatin Annual Profit & Loss
All figures in USD
Palatin Balance Sheet
All figures in USD Million
Palatin Cash Flow
All figures in USD Million
Corporate Actions
About Palatin
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. It is also developing, dependent on resources for development activities, MC1R agonist products, with potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. It has one operating segment life science.
Palatin Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $5.08 | $5.11 | +4.39% |
Oct 2026 | $8.82 | $4.89 | -49.25% |
Sep 2026 | $9.25 | $9.64 | -3.84% |
Aug 2026 | $8.12 | $10.03 | +30.26% |
Jul 2026 | $10.65 | $7.70 | -27.29% |
Jun 2026 | $14.35 | $10.59 | -26.71% |
May 2026 | $17.50 | $14.45 | -30.89% |
Apr 2026 | $18.74 | $20.91 | +10.81% |
Mar 2026 | $21.41 | $18.87 | -7.95% |
Feb 2026 | $16.25 | $20.50 | +37.45% |
Jan 2026 | $15.70 | $14.91 | -0.50% |
Dec 2025 | $19.80 | $14.99 | -19.93% |